4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-17-002735
Options or other derivatives
- Chief Medical Officer acquired 545,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Benaim Ely · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-01-20 | Grant or award : show line 1 in the form Stock Option (right to buy) | +450,000 | $0.18 | 2027-01-20 | 450,000 | 450,000 | D |
| 2017-01-20 | Grant or award : show line 2 in the form Restricted Stock Units | +95,000 | 95,000 | 95,000 | D |
Loading xslF345X03/form4.xml…